Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool April 29, 2011 Arundhati Parmar	Medtronic Stands to Gain From Likely CMS Reversal on MRI-Safe Pacemakers Is this a big opportunity for Medtronic?
The Motley Fool July 6, 2007 Billy Fisher	Medtronic: For the Broken-Hearted Promising clinical trial could bring a new Medtronic stent to market. Investors, take note.
The Motley Fool May 10, 2011 Arundhati Parmar	Medtronic's MR-Conditional Pacemaker Likely Too Expensive Is Medtronic's pricing choice dragging on this breakthrough product?
The Motley Fool May 26, 2004 Alyce Lomax	Medtronic Takes Heart After the stock drops on data, what does the company have to say?
BusinessWeek March 7, 2005	Dr. Oesterle's Stimulating Work Medtronic's chief medical officer, Dr. Stephen N. Oesterle, discusses the progress and potential of using "implanted pulse generators" to treat chronic ailments.
The Motley Fool January 6, 2005 Stephen D. Simpson	Can Medtronic Still Quicken the Pulse? While increased competition looms for the medical device maker, a shareholder update looks to the past.
BusinessWeek March 7, 2005 Michael Arndt	"Pacemakers" for the Rest of You Slews of tiny devices that deliver electrical stimulation to a wide variety of organs should soon become available.
The Motley Fool August 4, 2011 Arundhati Parmar	Medtronic Infuse Device Will Be Reviewed by Yale Researchers Medtronic works with Yale on a first-of-its-kind independent review.
The Motley Fool May 26, 2005 Stephen D. Simpson	A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges?
The Motley Fool July 13, 2011 Arundhati Parmar	FDA OKs Study Design on Medtronic Product That Firm Is Bullish On The product is the Simplicity catheter-based system to treat hypertension, or high blood pressure.
The Motley Fool February 17, 2009 Brian Orelli	Investors Heart Medtronic The leaner company is more lovable.
The Motley Fool February 24, 2009 Brian Orelli	Medtronic Hearts Acquisitions Medical device maker Medtronic pays a little over $1 billion for two acquisitions in one day.
BusinessWeek October 29, 2007 Arlene Weintraub	Medtronic's Uncertain Endeavor The drug-coated stent might have made up for Medtronic's recent product recall, but renewed scrutiny of the device has executives scaling back expectations
The Motley Fool November 17, 2010 Bryan Hinmon	Rising Star Buy: Medtronic Find out why this medical technology giant takes a place in our Un Portfolio.
The Motley Fool December 29, 2011 Harsh Chauhan	Why Medtronic Is On Course for a Happy New Year Right moves make Medtronic a good investment now.
Chemistry World July 18, 2012 Andrew Turley	Obesity drug approved in US US regulators have approved a new obesity treatment. Qsymia (phentermine, topiramate) tablets have been approved for overweight adults as part of a regimen that includes a low calorie diet and exercise.
BusinessWeek July 5, 2004	The Heart Is Just the Start CEO Art Collins explains how Medtronics is moving into treating spinal injuries, neurological disorders, diabetes, and more.
BusinessWeek July 5, 2004 Michael Arndt	High Tech -- And Handcrafted Despite a recent recall, medical-products maker Medtronic sets the quality standard for heart care.
The Motley Fool November 18, 2008 Brian Orelli	No Buffer for Medtronic Even though sales grew for the quarter, investors weren't happy.
The Motley Fool August 18, 2005 Stephen D. Simpson	Medtronic Keeps the Beat Strong growth in the ICD and spinal businesses keep Medtronic running. The stock is trading more or less at par to the market with respect to its P/E-to-growth ratio. Investors must decide for themselves whether that's a fair price to pay.
BusinessWeek May 29, 2006 Gene G. Marcial	Will Medtronic's Pulse Quicken? Some investors say Medtronic may beat analysts' consensus forecast.
The Motley Fool May 19, 2009 Brian Orelli	Medtronic Gets Whacked, Seeks Recovery Device Medtronic gets hammered on lackluster guidance.
The Motley Fool June 2, 2004 Brian Gorman	New Injection for Genzyme A partnership with Medtronic bolsters Genzyme's myoblast cell therapy program.
The Motley Fool August 24, 2011 Arundhati Parmar	Growth Is the Deity Medtronic CEO Omar Ishrak Will Worship CEO Omar Ishrak repeatedly said that a singular focus on growth would be his top priority to transform the company.
The Motley Fool October 16, 2007 Billy Fisher	A Heartbreaker at Medtronic The medical device maker halts distribution of certain defibrillator wires. Shares of Medtronic are now very close to the stock's 52-week low.
The Motley Fool November 24, 2009 Brian Orelli	52-Week Highs! What's Going On? Even with its recent leap, this stock may belong in your portfolio. Medtronic raised earnings guidance today after a fairly strong quarter, and the stock is hitting new 52-week highs.
The Motley Fool August 20, 2008 Brian Orelli	Medtronic Muddles Through The medical device maker manages double-digit growth in a tough market.
The Motley Fool July 16, 2010 Tom Hughes	Lessons Learned About the Outlook for New Obesity Drug Approval The recent FDA advisory committee meeting on Vivus' weight loss pill proved to us, once again, how incredibly difficult it is to successfully develop and register new drugs for obesity.
BusinessWeek March 7, 2005 Michael Arndt	Rewiring The Body First came pacemakers. Now exotic implants are bringing new hope to victims of epilepsy, paralysis, depression, and other diseases. And some of the biggest names in health care are in a scramble to get into the market.
The Motley Fool December 9, 2011 Harsh Chauhan	Medtronic Regains Its Footing Medtronic comes up with a strong quarter.
The Motley Fool November 18, 2004 W.D. Crotty	Medtronic Down, Not Out Internal defibrillator maker's earnings growth rate is slowing down, but its future looks healthy.
IEEE Spectrum March 2006 Samuel K. Moore	Psychiatry's Shocking New Tools Electronic implants and electromagnetic pulses are picking up where psychoactive drugs have failed.
The Motley Fool April 6, 2005 Stephen D. Simpson	Investing in Controlling Obesity While every investor must do their own due diligence, here is an outline of at least some of the major ways that investors can hope to profit from medical technology aimed at curing, or at least controlling, obesity..
Knowledge@Wharton March 26, 2003	An Aging, Fatter Population Drives Demand for New Medical Devices The use of implantable devices to treat heart disease, orthopedic complaints and other conditions is growing strongly because of advancing technology, increasing demand from an ageing and overweight population, and greater acceptance by physicians and patients of implantation.
The Motley Fool August 22, 2007 Ryan Fuhrmann	Upbeat About Medtronic The future looks bright at medical-device firm Medtronic, and the stock price is reasonable. First quarter sales grew, as overseas revenue improved an impressive 16%.
The Motley Fool May 25, 2005 W.D. Crotty	Medtronic's Sneak Preview The medical technology company, a 26-bagger, turns in another strong quarter and fiscal year, then offers quite an outlook.
The Motley Fool August 25, 2009 Brian Orelli	Medtronic Takes the Road Less Traveled It looks like this medical devices company is healthy again.
The Motley Fool June 3, 2011 Brian Orelli	FDA Bullies Obesity Drugmakers It's been clear for some time that the Food and Drug Administration isn't particularly fond of obesity drugs. Now it's just being a bully.
The Motley Fool February 17, 2005 Stephen D. Simpson	Is Medtronic's Heartbeat Slowing? Will gradually decelerating growth lead to a multiple contraction on the medical device maker's stock?
The Motley Fool March 3, 2011 Bryan Hinmon	Medtronic's Moat Is Strengthening Lessons from an interview with Medtronic CFO Gary Ellis.
The Motley Fool August 18, 2008 Brian Orelli	Foolish Forecast: Taking Medtronic to Heart In advance of earnings analysts expect Medtronic, with another medical device approval, to boost revenues 17%.
The Motley Fool November 18, 2011 Brian Orelli	Medtronic: Cutting Fat and Growing Margins The company announces that it has sold Physio-Control to private-equity fund Bain Capital.
The Motley Fool February 20, 2008 Brian Orelli	Medtronic Looks Ahead After a rough second half of last year, Medtronic is leaving its problems behind, and optimistically focusing on the future.
The Motley Fool February 24, 2010 Brian Orelli	Medtronic Needs to Regrow a Spine Everything else looks fairly good, but the problem I see involves the slight decline in Medtronic's second-largest segment, spinal products.
The Motley Fool May 24, 2007 Ryan Fuhrmann	Chronic Healthiness at Medtronic The med-tech firm isn't growing as fast as it once was, but its fourth-quarter earnings report still managed to beat Wall Street's expectations.
The Motley Fool October 22, 2011 Harsh Chauhan	This Stock May Be a Surprisingly Good Buy Medtronic's moves could reap dividends in the future.
The Motley Fool April 5, 2005 Stephen D. Simpson	Can Obesity Fatten Your Wallet? Obesity is an increasingly serious problem, but could it also be a major opportunity for health-care companies? Investors should spend a little due diligence on the pharmaceutical side.
The Motley Fool August 24, 2010 Brian Orelli	Disaster in Medical-Device Land Industry bellwether Medtronic is forecasting a nasty storm.
The Motley Fool May 21, 2008 Brian Orelli	Medtronic's Endeavors Look Good The medical device maker's new drug-eluting stent helps push up revenue.
The Motley Fool August 6, 2011 Arundhati Parmar	Medtronic Jobs: Firm Will Double Chinese Workforce in 4 Years The company puts its focus on emerging markets.